FDA shakes up top lead­er­ship around gener­ic drugs

Pa­trizia Cavaz­zoni, head of the FDA’s drug cen­ter, an­nounced via email to staff to­day that Iilun Mur­phy will take over as per­ma­nent di­rec­tor of the Of­fice of Gener­ic Drugs (OGD), re­plac­ing Su­san Rosen­crance, who has served as act­ing OGD di­rec­tor since Oc­to­ber.

But OGD is al­so get­ting a clos­er look from the very top of FDA as re­cent gener­ic can­cer drug short­ages have led to new im­ports from Chi­na, in ad­di­tion to new safe­ty ques­tions re­lat­ed to the US mil­i­tary re-test­ing gener­ics (see this Bloomberg sto­ry yes­ter­day).

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER